Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Ramnath

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
American Journal of Clinical Oncology|August 1, 1997
Phase II evaluation of cisplatin and WR2721 for refractory metastatic breast cancerN Ramnath, P LoRusso, M Simon, et al.
The Journal of Thoracic and Cardiovascular Surgery|June 28, 2003
No benefit of intraoperative whole blood sequestration and autotransfusion during coronary artery bypass grafting: results of a randomized clinical trialA N Ramnath, H R Naber, A de Boer, et al.
Cancer Immunology, Immunotherapy : CII|September 28, 2005
Is downregulation of MHC class I antigen expression in human non-small cell lung cancer associated with prolonged survival?N Ramnath, D Tan, Q Li, et al.
Anticancer Research|January 19, 1999
Activity of 9-cis-retinoic acid and receptor-selective retinoids in small cell lung cancer cell linesR Rosati, N Ramnath, M R Adil, et al.
Occupational and Environmental Medicine|January 10, 2008
Wood dust exposure and the risk of upper aero-digestive and respiratory cancers in malesV Jayaprakash, K K Natarajan, K B Moysich, et al.
Oncology|May 22, 2008
Hormone replacement therapy as a risk factor for non-small cell lung cancer: results of a case-control studyN Ramnath, R J Menezes, G Loewen, et al.
Oncology|November 13, 2004
A phase I and pharmacokinetic study of BAY59: a novel taxaneN Ramnath, J Hamm, G Schwartz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 16, 2001
MCM2 is an independent predictor of survival in patients with non-small-cell lung cancerN Ramnath, F J Hernandez, D F Tan, et al.
Cancer Chemotherapy and Pharmacology|February 26, 2013
A phase I/II pharmacokinetic and pharmacogenomic study of calcitriol in combination with cisplatin and docetaxel in advanced non-small-cell lung cancerN Ramnath, S Daignault-Newton, G K Dy, et al.
Cancer Chemotherapy and Pharmacology|June 11, 2005
S-phase modulation by irinotecan: pilot studies in advanced solid tumorsN Ramnath, N Khushalani, K Toth, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
American Journal of Clinical Oncology|August 1, 1997
Phase II evaluation of cisplatin and WR2721 for refractory metastatic breast cancerN Ramnath, P LoRusso, M Simon, et al.
The Journal of Thoracic and Cardiovascular Surgery|June 28, 2003
No benefit of intraoperative whole blood sequestration and autotransfusion during coronary artery bypass grafting: results of a randomized clinical trialA N Ramnath, H R Naber, A de Boer, et al.
Cancer Immunology, Immunotherapy : CII|September 28, 2005
Is downregulation of MHC class I antigen expression in human non-small cell lung cancer associated with prolonged survival?N Ramnath, D Tan, Q Li, et al.
Anticancer Research|January 19, 1999
Activity of 9-cis-retinoic acid and receptor-selective retinoids in small cell lung cancer cell linesR Rosati, N Ramnath, M R Adil, et al.
Occupational and Environmental Medicine|January 10, 2008
Wood dust exposure and the risk of upper aero-digestive and respiratory cancers in malesV Jayaprakash, K K Natarajan, K B Moysich, et al.
Oncology|May 22, 2008
Hormone replacement therapy as a risk factor for non-small cell lung cancer: results of a case-control studyN Ramnath, R J Menezes, G Loewen, et al.
Oncology|November 13, 2004
A phase I and pharmacokinetic study of BAY59: a novel taxaneN Ramnath, J Hamm, G Schwartz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 16, 2001
MCM2 is an independent predictor of survival in patients with non-small-cell lung cancerN Ramnath, F J Hernandez, D F Tan, et al.
Cancer Chemotherapy and Pharmacology|February 26, 2013
A phase I/II pharmacokinetic and pharmacogenomic study of calcitriol in combination with cisplatin and docetaxel in advanced non-small-cell lung cancerN Ramnath, S Daignault-Newton, G K Dy, et al.
Cancer Chemotherapy and Pharmacology|June 11, 2005
S-phase modulation by irinotecan: pilot studies in advanced solid tumorsN Ramnath, N Khushalani, K Toth, et al.
Pageof 1